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Abstract
The purpose of this study was to assess the incidence and risk factors associated with 
postoperative nausea (PON) and vomiting (POV) after orthognathic surgery. A review of the 
clinical records of consecutively enrolled subjects (2008–2012) at a single academic institution 
was conducted between 9/2013 and 3/2014. Data on the occurrence of PON and POV and 
potential patient-related, intraoperative, and postoperative explanatory factors were extracted from 
the medical records. Logistic models were used for the presence/absence of postoperative nausea 
and vomiting separately. Data from 204 subjects were analyzed: 63% were female, 72% 
Caucasian, and the median age was 19 years. Thirty-three percent had a mandibular osteotomy 
alone, 27% a maxillary osteotomy alone, and 40% had bimaxillary osteotomies. Sixty-seven 
percent experienced PON and 27% experienced POV. The most important risk factors for PON in 
this series were female gender, increased intravenous fluids, and the use of nitrous oxide, and for 
POV were race, additional procedures, and morphine administration. The incidence of PON and 
POV following orthognathic surgery in the current cohort of patients, after the introduction of the 
updated 2007 consensus guidelines for the management of postoperative nausea and vomiting, has 
not decreased substantially from that reported in 2003–2004.
© 2015 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd.
Correspondence: Ceib Phillips, Department of Orthodontics, University of North Carolina at Chapel Hill 101 Manning Dr CB 7450 
Chapel Hill NC 27599 USA, Tel: +1 919 537 3373, Fax: +1 919 864 8842, Ceib_Phillips@unc.edu. 
Competing interests
The authors have no conflict of interest disclosures.
Ethical approval
This study (#03-1642) was reviewed by the Biomedical Institutional Review Board, University of North Carolina, Chapel Hill, NC, 
USA.
Patient consent
Patient consent was required and obtained.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of 
Health.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
Int J Oral Maxillofac Surg. Author manuscript; available in PMC 2016 June 01.
Published in final edited form as:














orthognathic surgery; postoperative nausea; postoperative vomiting
Introduction
Postoperative nausea and vomiting (PONV) remains one of the most frequent and 
distressing complications following both inpatient and outpatient surgical procedures. 
PONV has received considerable attention for multiple reasons. Patients have reported that 
PONV is of greater concern than postoperative pain1–4, and patient dissatisfaction after 
anesthesia has been associated significantly with the occurrence of PONV5,6. A recent 
systematic review reported that 36% of patients in the general surgical population 
experience PONV (range 18–45%)7. In certain high-risk patients, the prevalence of PONV 
may approach 80%8.
Although many types of surgery have been linked to an increased experience of PONV, 
including ophthalmological, laparoscopic, and gynecological surgery, the influence of 
surgery type remains controversial7–12. The only large retrospective review of PONV after 
orthognathic surgery reported that 40% of patients experienced PONV during the first 24 h 
after surgery, with a particularly high prevalence (56%) after bimaxillary osteotomies13.
PONV has been shown to increase healthcare costs through extended recovery room stays, a 
delay to discharge, and unplanned admissions after intended outpatient procedures14–17. In 
patients undergoing intraoral procedures, PONV can lead to intraoral bleeding with 
continued swallowing of blood, potentially prolonging PONV. Maxillomandibular elastic 
traction can magnify the anxiety and agitation associated with PONV. However, the risk of 
PONV varies widely based on patient-related, intraoperative, and postoperative risk 
factors2,8. Two commonly used scores for the risk assessment of PONV are the Koivuranta 
score2 and the Apfel score8.
On a systems level, postoperative nausea (PON) and postoperative vomiting (POV) are 
frequently considered and reported as a single unit. However, in terms of pathophysiological 
pathways, healthcare costs, and the patient’s sense of well-being, there are important 
differences between nausea and vomiting. Although nausea may decrease a patient’s sense 
of well-being and increase anxiety, nausea alone poses no significant health risks. In 
contrast, vomiting can potentially result in significant health risks such as hematoma, wound 
dehiscence, dehydration, electrolyte imbalances, and, in extreme cases, esophageal damage 
or aspiration18. The patient’s perception of nausea and vomiting also differ. Pre-surgery 
patients ranked emesis as the most undesirable and nausea as the fourth most undesirable 
anticipated negative postoperative outcome3. Gagging on the tracheal tube ranked second 
and pain ranked third. In another study examining patient perceptions of PONV, Gan et al.4 
found that patients were, on average, willing to pay US$56 out-of-pocket to avoid PONV 
and that this amount increased to US$73 for patients who had experienced PON and to US
$100 in patients who had experienced POV.
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In an ongoing assessment of recovery following orthognathic surgery using a daily diary, 
our group has seen little change in the proportion of patients reporting issues with nausea/
vomiting after discharge (unpublished data). This led us to query whether the occurrence of 
PONV in a recent cohort of orthognathic surgery patients, following the implementation of 
the Society for Ambulatory Anesthesia guidelines for the management of postoperative 
nausea and vomiting in 200719, was similar to that reported earlier by Silva et al.13. We 
further questioned whether, given the underlying biological as well as patient-centered 
differences, there were independent risk factors for PON and POV.
Materials and methods
Consecutive subjects from an institutional review board-approved study who underwent 
orthognathic surgery with or without additional procedures from 1 June 2008 to 30 June 
2012 were enrolled in the present study. Only individuals aged between 14 and 60 years 
with a dentofacial disharmony due to a developmental problem severe enough to warrant 
surgical treatment and who were American Society of Anesthesiology (ASA) I or II status 
were eligible for enrollment. Exclusion criteria included the presence of a congenital 
syndrome, previous facial surgery, recent facial trauma, a systemic medical condition with 
degenerative, immunosuppressive, musculoskeletal, or neuropathy sequelae, and the 
inability to follow verbal or written instructions in English. A research associate described 
the project to each subject and obtained written consent or assent with parental permission 
and Health Insurance Portability and Accountability Act (HIPAA) authorization to review 
the clinical records. Analysis of the medical records occurred between September 2013 and 
March 2014.
All patients were interviewed before surgery by the anesthesia provider. Anesthetic agents 
varied and included nitroprusside and inhalation agents and were determined by the 
anesthesiologist. All osteotomies were performed under controlled hypotension. All 
orthognathic surgical procedures were performed by oral and maxillofacial surgery faculty 
and residents at the university. A throat pack was placed during the procedure and a 
nasogastric tube (vented nasogastric tube) was used to evacuate the gastric contents at the 
conclusion of each procedure. For some Le Fort I osteotomy patients the nasogastric tube 
remained in place overnight (approximately 12 h) and was then removed. Rigid fixation was 
used to stabilize the osteotomy sites. Maxillomandibular elastic traction was used 
postoperatively for all patients. Subjects recovered in the post anesthesia care unit (PACU) 
prior to transfer to the short stay unit (SSU) after mandibular osteotomy, or to the floor after 
maxillary osteotomy or bimaxillary surgery. Medications were provided on an ‘as needed 
basis’ after transfer. The same medications were used in the SSU and on the floor. The 
dosage and type of medication was determined by the attending physician.
Potential patient-related, intraoperative, and postoperative variables were extracted from 
medical records independently by two examiners. Discordance between reviewers was 
resolved by joint re-review of the records followed by a consensus decision. Patients with 
incomplete or illegible medical records were excluded from this study. A risk score defined 
as the number of patient-related risk factors for PONV present (female gender, non-smoking 
status, and history of PONV or motion sickness or migraine headaches) was calculated and 
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categorized8,9. Intraoperative surgery-related risk factors included duration of surgery, 
surgery type (mandibular osteotomy alone vs. Le Fort I osteotomy alone vs. Le Fort I and 
mandibular osteotomies), and whether additional procedures were performed12,15,19. Other 
intraoperative variables included the use of volatile agents, nitrous oxide, anti-emetics, and 
fluids administered in milliliters per kilogram (ml/kg)19–21. Postoperative variables included 
analgesics given in the PACU and in the SSU and on the floor, as well as postoperative 
steroid dosing regimens.
A patient was considered to have PON if nausea was noted in the nursing or resident notes 
or if rescue medications for nausea were administered while the patient was in the hospital, 
and/or to have POV if emesis was noted in the intake or output record. The occurrence of 
nausea and emesis was recorded, as was the time to first recorded nausea. The length of the 
hospital stay was also noted.
Statistical analysis
A bivariate analysis was performed to compare those who experienced nausea vs. those who 
did not, and those who experienced emesis vs. those who did not using χ2 tests for nominal 
explanatory variables and Wilcoxon rank sum tests for continuous explanatory variables. 
Logistic models were used for the binary outcomes (yes or no) of PON and POV separately. 
A forward selection method with entry level of 0.05 was used. Three sets of potential 
explanatory variables (patient-related, intraoperative, and postoperative medications) were 
evaluated sequentially for inclusion in the model. Statistically significant predictors from the 
patient-related set were forced into the intraoperative set. Significant predictors from the 
intraoperative and patient-related sets were included in the final selection model. Age at 
surgery and length of surgery were centered (19 years and 160 min, respectively) and 
standardized so that each unit of age represented 5 years and each unit of length of surgery 
represented 5 min.
Results
The medical records of 252 subjects were reviewed. These patients had undergone 
orthognathic surgery between June 2008 and June 2012, had consented to participate in this 
institutional review board-approved prospective observational study prior to surgery, and 
had given HIPAA authorization for review of all clinical records.
Of the 204 patients included in the analysis, 63% were female and 72% were Caucasian. 
Subjects ranged in age from 14 to 57 years (median 19 years; interquartile range (IQR) 17–
24 years). Fifty-eight percent (n = 117) were of normal weight or underweight (body mass 
index (BMI) <25 kg/m2), 21% (n = 42) were overweight (BMI 25–30 kg/m2), and 21% 
obese (BMI ≥30 kg/m2). When evaluating the sum of risk factors (female, non-smoking 
status, and history of PONV or motion sickness or migraines), 33% had at most one, 51% 
two, and 16% had three or more risk factors (Table 1). Female gender and non-smoking 
status were the two most frequent risk factors.
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Operative, intraoperative anesthesia, and medication related factors
Thirty-three percent had a mandibular osteotomy alone, 27% had a maxillary osteotomy 
alone, and 40% had bimaxillary osteotomies. Forty-four percent had at least one additional 
procedure: of these, 45% had removal of third molars, 32% a genioplasty, and 24% 
mandibular bone harvest. The median duration of surgery was 159 min (IQR 111–223 min) 
(Table 1).
Fifty-four percent of the subjects received nitrous oxide: 34% for part of the case and 20% 
for the entire case. Thirty-two percent (n = 65) did not receive neostigmine, 28% (n = 58) 
received up to 2.5 mg neostigmine, and 40% (n = 81) received 2.5 mg or more of 
neostigmine. Forty-eight percent (n = 98) received droperidol. Analysis of the records 
indicated a lack of standardized anesthesia and medication protocols.
Only one patient did not receive any anti-emetics. Seventy-four (36%) received ketorolac 
and 48% (n = 98) received morphine during their stay.
Postoperative factors
Of the 137 subjects who had a Le Fort I osteotomy, 77 (56%) had a nasogastric tube left in 
place overnight. Thirty-five percent of patients received oxycodone during their hospital 
stay, substantially more than received hydrocodone (12%). Sixty-one percent received 
acetaminophen with codeine (Table 1).
PON and POV
According to the medical records, 67% of subjects experienced nausea and 27% vomited in 
the hospital (Fig. 1). A higher percentage of patients who had osteotomies in both the 
maxilla and mandible experienced nausea and vomiting than those who had only a single 
jaw osteotomy (Table 1), but the difference in frequency was not statistically significant for 
either nausea (P = 0.14) or emesis (P = 0.28). Further, the average time to the first 
occurrence of nausea (4.5 h for maxillary only and bimaxillary patients and 5 h for 
mandibular only patients) was not significantly different among the three types of surgery (P 
= 0.89). Of the patients who had a Le Fort I osteotomy, there was no statistically significant 
difference in the proportions of patients who experienced nausea (P = 0.51) or vomiting (P = 
0.4) between those for whom the nasogastric tube was removed immediately after surgery 
and those for whom the nasogastric tube was kept in overnight.
The average length of stay in the hospital in hours was significantly different among the 
three surgery groups (P = 0.0001), with the patients who had a bimaxillary procedure 
staying on average 38 h, while those who had a single jaw osteotomy stayed 26 h. There was 
no statistically significant difference in the average hospital stay across the three surgery 
groups for those who experienced nausea and those who did not (P = 0.52), but there was for 
those who vomited versus those who did not (P = 0.03). The average length of stay was 
quite similar for those patients who had a single jaw osteotomy, but the patients who had 
osteotomies in both jaws and vomited stayed on average 15 h longer than those who did not 
vomit (Table 1).
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Association between potential risk factors and PON and POV
Simple cross-tabulations of potential risk factors and the occurrence of nausea (PON) and 
vomiting (POV) during the patients’ hospital stay are reported in Table 1. Females were 
more likely to experience nausea in the hospital than males (P = 0.03), but not emesis (P = 
0.56). Age, the number of risk factors, and BMI were not associated with nausea or emesis 
(all P > 0.15). The percentage of Caucasians who experienced vomiting was significantly 
lower than for non-Caucasians (P = 0.04). The median length of surgery in those who had 
nausea was substantially longer (P = 0.04), by almost 35 min. The use of intravenous fluids 
was significantly associated with nausea (P = 0.04): a higher percentage of subjects who 
received ≥25 ml/kg of intravenous fluids experienced nausea than those who received <25 
ml/kg. Patients who did not receive droperidol were slightly more likely to experience 
nausea (P = 0.07) and were significantly more likely to experience emesis (P = 0.04) (Table 
1).
The results of sequential logistic regression indicated that the likelihood of PON was 
statistically significantly affected by the sex of the patient (P = 0.02), the use of nitrous 
oxide (P = 0.02), and the amount of intravenous fluid used (P = 0.03) (Table 2). The odds of 
experiencing postoperative nausea was 2.12 times higher for females than males, and the 
likelihood of nausea increased 1.99 times if the patient received 25 ml/kg of intravenous 
fluids. Patients who received partial or full case nitrous oxide were 2.17 times more likely to 
experience postoperative nausea than those who did not receive nitrous oxide.
The likelihood of postoperative emesis was statistically significantly affected by the race of 
the patient (P = 0.01), BMI (P = 0.035), additional surgical procedures (P = 0.02), and the 
number of morphine doses received (P = 0.01). Non-Caucasians were substantially more 
likely (odds ratio (OR) 2.49 times) to experience postoperative emesis than Caucasians, 
while patients who were obese (BMI ≥30 kg/m2) were 0.34 times less likely to experience 
emesis than those who were overweight and 0.43 times less likely to experience emesis than 
those who were underweight or of normal weight. The risk of emesis was increased 2.26 
times for subjects who had an additional surgical procedure. The likelihood of emesis 
increased 1.09 times for each additional dose of morphine given (Table 2).
Discussion
Potential risk factors
Numerous risk factors related to the development of PONV have been suggested. Potential 
risk factors evaluated in our study included female gender2,7,8,10–12, younger age in 
adults7,11,12, history of PONV and/or motion sickness2,7,10,20, duration of surgery/
anesthesia2,7,10,12, use of nitrous oxide7,20, and postoperative opioid administration10,20, all 
of which have been studied extensively and are established risk factors for PONV. Although 
non-smoking status2,7,12,20 and the use of volatile anesthetics7,20 are also established 
independent risk factors, these variables were not analyzed as nearly all subjects received a 
volatile agent during anesthesia and the vast majority were non-smokers. The influence of 
neostigmine is controversial11,22,23. The influence of the use of an indwelling nasogastric 
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tube in those undergoing Le Fort I osteotomy was also explored, although the benefit of 
gastric decompression is also debatable20,24,25.
Postoperative nausea and vomiting
This study reports a high prevalence of both PON (67%) and POV (27%) following 
orthognathic surgery. Previous reports have confirmed the strong correlation between nausea 
and vomiting10, but have also noted that the occurrence of the subjective conscious 
sensation of nausea is not always followed by the complex reflex under the control of the 
vomiting center. While anti-emetic drugs are frequently prescribed once nausea is 
experienced, these drugs are generally considered to have more anti-nausea efficacy than 
anti-emetic efficacy and do carry some adverse effect risk11.
Patient-related potential risk factors
In this study, as in others2,8–12, females were more likely to experience PON. A recent 
systematic review reported an OR of 2.47 for PONV based on female gender7. Female 
gender remained a significant risk factor for PON in the logistic regression analysis in the 
present study, with an OR of 2.12. Interestingly, there was no association between gender 
and POV, contrary to the findings reported by Stadler et al.10. The difference in findings 
may be related to the statistical approach: the early findings were based on the inclusion of 
only gender as an explanatory factor, while in this study the findings were based on a 
hierarchical structure to identify those factors that provide the contribution to the 
explanation after accounting for other confounding factors in the model. Female gender was 
still statistically significant even after accounting for the effect of the use of nitrous oxide 
and intravenous fluids.
Non-Caucasian subjects were statistically significantly more likely to have POV (OR 2.49) 
but not PON than Caucasian subjects. Although the country of origin has been associated 
with PONV in some studies26, most have shown no association between race and 
PONV13,19,27.
BMI was not significantly associated with PON or POV in the bivariate analysis. However, 
in the logistic regression analysis, BMI was associated with POV. Obese subjects (BMI ≥30 
kg/m2) were 0.34 times less likely than overweight (BMI 25–29.9 kg/m2) subjects to 
experience POV. However, when compared to normal weight subjects, obese subjects 
merely trended towards less POV. The most recent clinical guidelines report that BMI has 
little clinical relevance to PONV11, although Silva et al.13 did find a trend towards less 
PONV as BMI increased.
Age was not a significant risk factor for PON or POV in this series. The largest retrospective 
study on PONV in orthognathic surgery patients did note that PONV decreased with age13, 
and other studies have also reported a decreased experience of PONV with increasing age in 
adults7,11,12. The distribution of age in this study was quite different from that reported 
earlier13, which may account for the lack of an association between age and PONV. The 
median age in this study was 19 years and 75% of the subjects were aged ≤24 years. In the 
earlier13 study, the mean age was 31 years and only 46% of subjects were aged ≤25 years; 
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additional subjects in the older age brackets likely offered additional power to detect 
differences in PONV with increasing age.
The total number of classical risk factors (female gender, non-smoking status, and history of 
PONV or motion sickness or migraine headaches) was not associated with PON or POV. 
However, almost two-thirds of the subjects in this series were female, and female gender 
was significantly associated with nausea. The other issue is that the data were gathered from 
medical record audits with the assumption that pertinent risk factors were inquired about and 
recorded accurately.
Intraoperative potential risk factors
The use of nitrous oxide was associated with an increase in the proportion of patients who 
experienced PON, both in the simple bivariate analysis (PON 73% vs. 59%, P = 0.04) and in 
the logistic regression analysis after controlling for other factors (OR 2.17, P = 0.02). 
Although there was a trend towards more POV with nitrous oxide, this was not statistically 
significant. Nitrous oxide has been indicated as an independent risk factor for PONV11, but 
was not related to PONV in the series of Silva et al.13 on orthognathic surgery patients. In a 
systematic review on the effect of nitrous oxide on PONV in adults, the avoidance of nitrous 
oxide had the largest reduction effect on PONV in women28.
The impact of neostigmine on PONV is controversial; in our series it did not influence PON 
or POV. Surprisingly, there was actually a trend towards more PON and POV in subjects 
who received less neostigmine, which is in contrast to prior results suggesting that a high 
dose of neostigmine (>2.5 mg) is associated with increased PONV23. Nonetheless, the most 
recent Society for Ambulatory Anesthesiology (SAMBA) consensus guidelines state that 
evidence for the influence of neostigmine on PONV is uncertain, and the minimization of 
neostigmine as a strategy to reduce the risk of PONV has been removed from the 
guidelines11,19,20.
Although consensus guidelines encourage hydration to minimize the risk of PONV11,19,20, 
the subjects in this series who received ≥25 ml/kg of intravenous fluids were actually more 
likely to experience PON even after controlling for other risk factors. One explanation for 
this finding is that increased hydration reflects an increased duration of anesthesia and that 
its favorable influence is eliminated by the heightened risk of PONV due to increased 
surgery duration.
Only one patient did not receive any anti-emetics. Those subjects treated prophylactically 
with droperidol were less likely to experience POV (20% vs. 33%, P = 0.04) and tended 
towards less PON (60% vs. 73%, P = 0.07) in the bivariate analysis.
Leaving a nasogastric tube in place overnight after Le Fort I osteotomy did not influence the 
occurrence of PON or POV. Consensus guidelines11 state that the use of a nasogastric tube 
has been disproven as a method to decrease PONV; our findings support this in terms of an 
indwelling tube. However, given the emetogenic nature of blood and the clinical observation 
that orthognathic surgery patients often report improved nausea after vomiting old blood, the 
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evacuation of gastric contents at the end of surgery appears to be a low risk and potentially 
helpful adjunct procedure.
Although slightly more subjects who had a Le Fort I osteotomy with or without a 
mandibular osteotomy experienced nausea and vomiting than did subjects who underwent 
mandibular osteotomies alone, this difference was not statistically significant (PON 70% vs. 
60%, P = 0.14; POV 29% vs. 24%, P = 0.49). In contrast, Silva et al.13 reported a 
statistically significant increase in PONV when a maxillary osteotomy was performed, with 
the highest prevalence of PONV in patients who underwent bimaxillary surgery. The 
previous study13 hypothesized that increased swallowing of blood and, potentially, 
deliberate hypotension, contributed to the increased experience of PONV. The previous 
study, however, reported a composite outcome (nausea or vomiting) rather than an 
assessment of the separate outcomes.
In general the impact of surgery type on PONV remains unclear11,20. Maxillofacial surgery 
was cited as a high-risk surgery in the 2007 SAMBA consensus guidelines19 on PONV, 
however it was not included in the high-risk surgery types mentioned in the most recent 
2014 guidelines11. Nevertheless, based on the high prevalence of PON and POV in this 
series and that of Silva et al.13, consideration should be given to orthognathic surgery as a 
high-risk surgery type.
Anesthesia/surgery duration is a known risk factor for PONV7,11,20 and was associated with 
PON in this study in the bivariate analysis. It has been reported that a duration of surgery 
greater than 60 min increases a patient’s risk of experiencing both PON and POV2 and that a 
30-min increase in surgical time predicts a 60% increase in the risk of PONV12. In our 
series, the average duration of surgery was statistically significantly longer for those who 
experienced PON (176.5 vs. 141.5 min, P = 0.04), but not POV (167.0 vs. 150.0 min, P = 
0.28). Surgery duration was longer in our series than in the series reported previously13; this 
may reflect the frequency of additional procedures or the involvement of residents in every 
case. Although surgery time was not a statistically significant factor in the logistic 
regression for either PON or POV, the administration of intravenous fluids ≥25 ml/kg 
significantly increased the risk of PON, and additional procedures increased the risk of 
emesis. Both of these measures are likely related to and increase the duration of surgery.
PONV postoperative potential risk factors
It is well established that the use of perioperative opioids is associated with PONV7,8,10,11. 
In this study, patients who received morphine were slightly more likely to experience 
emesis, with 1.09 times the likelihood of emesis for each dose, typically 2 mg, of morphine 
given.
In conclusion, this study demonstrates a high incidence of both PON and POV after 
orthognathic surgery, even after the updated 2007 consensus guidelines for the management 
of postoperative nausea and vomiting19. The results in this study echo those of the largest 
case series (2003–2004) that assessed PONV as a composite outcome13 prior to the 2007 
guidelines. The most important risk factors for PON in this series were female gender, 
increased intravenous fluids (potentially reflecting increased surgery duration), and the use 
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of nitrous oxide. The most important risk factors for POV were race, additional procedures 
(likely reflecting longer surgery duration), and morphine administration. Simple risk 
assessments have been proposed for PONV2,7, but usage is complicated in the orthognathic 
surgery population by multiple factors: (1) the low sensitivity and specificity of these scores 
(65–70%), (2) the debate over the prophylactic use of anti-emetic medications, and (3) the 
differences between nausea and vomiting as medical risks. Although medical chart audits 
have substantial drawbacks, such assessments provide valuable comparison data for future 
evaluations on anesthesia strategies aimed at the reduction of PONV and for comparative 
studies examining the effectiveness of updates to consensus guidelines on the incidence of 
PONV.
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